Skip to content
Capsul News Capsul News
3 min read

The Long View: Chasing The Dupixent Orbit

The atopic dermatitis benchmark keeps moving. AbbVie is setting up a challenger and Sanofi/Regeneron are not resting on their Dupixent laurels.

An ornate golden throne with red velvet upholstery and lion armrests against a dark background.
Everyone wants to sit here. Not everyone gets to. Photo by Sai Madhav on Unsplash
Share Share Share Email

Read next

Therapeutic Thursday: Another One Bites The Dust

Milestone Monday: Biopharma IPOs Are Playing To A Friendly House